Article

Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication

Lineberger Comprehensive Cancer Center and Division of Infectious Diseases, Department of Medicine and Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7292.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 12/2012; 110(5). DOI: 10.1073/pnas.1213515110
Source: PubMed

ABSTRACT

Hepatitis C virus (HCV) replication is dependent on microRNA 122 (miR-122), a liver-specific microRNA that recruits Argonaute 2 to the 5' end of the viral genome, stabilizing it and slowing its decay both in cell-free reactions and in infected cells. Here we describe the RNA degradation pathways against which miR-122 provides protection. Transfected HCV RNA is degraded by both the 5' exonuclease Xrn1 and 3' exonuclease exosome complex, whereas replicating RNA within infected cells is degraded primarily by Xrn1 with no contribution from the exosome. Consistent with this, sequencing of the 5' and 3' ends of RNA degradation intermediates in infected cells confirmed that 5' decay is the primary pathway for HCV RNA degradation. Xrn1 knockdown enhances HCV replication, indicating that Xrn1 decay and the viral replicase compete to set RNA abundance within infected cells. Xrn1 knockdown and miR-122 supplementation have equal, redundant, and nonadditive effects on the rate of viral RNA decay, indicating that miR-122 protects HCV RNA from 5' decay. Nevertheless, Xrn1 knockdown does not rescue replication of a viral mutant defective in miR-122 binding, indicating that miR-122 has additional yet uncharacterized function(s) in the viral life cycle.

Download full-text

Full-text

Available from: David Mcgivern
  • Source
    • "Pre-miRNAs occur as thermodynamically stable hairpin structures that are exported to the cytoplasm via the protein exportin and processed to active 21–22 nucleotide mature miRNAs by RNA endonuclease Dicer within the RNA silencing complex (RISC). Mature miRNAs are further processed in RISC by selecting one of two strands (−5p or −3p) and guided to their cognate mRNAs where they facilitate destabilization and eventual degradation of the target , prevent translation via recruitment of inhibitory factors, or in some cases can enhance RNA stability (Krol et al., 2010; Li et al., 2013). Humans express an estimated 1881 pre-miRNAs which produce 2588 mature miRNAs (Kozomara and Griffiths-Jones, 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: miRNA clusters define a group of related miRNAs closely localized in the genome with an evolution that remains poorly understood. The miR-302/367 cluster represents a single polycistronic transcript that produces five precursor miRNAs. The cluster is highly expressed and essential for maintenance of human embryonic stem cells. We found the cluster to be highly conserved and present in most mammals. In primates, seed sequence and miRNA structure are conserved, but inter-precursor sequences are evolving. Insertions of new miRNAs, deletions of individual miRNAs, and a cluster duplication observed in different species suggest an actively evolving cluster. Core transcriptional machinery consisting of NANOG and OCT-4 transcription factors that define stem cells are present upstream of the miR-302/367 cluster. Interestingly, we found the miR-302/367 cluster flanking region to be enriched as a target site of other miRNAs suggesting a mechanism for feedback control. Analysis of miR-302 and miR-367 targets demonstrated concordance of gene set enrichment groups at high gene ontology levels. This cluster also expresses isomiRs providing another means of establishing sequence diversity. Finally, using three different kidney tumor datasets, we observed consistent expression of miR-302 family members in normal tissue while adjacent tumor tissue showed a significant lack of expression. Clustering expression levels of miR-302 validated target genes showed a significant correlation between miR-302/367 cluster miRNAs and a subset of validated gene targets in healthy and adjacent tumor tissues. Taken together, our data show a highly conserved and still evolving miRNA cluster that may have additional unrecognized functions.
    Full-text · Article · Sep 2015 · Comparative Biochemistry and Physiology Part D Genomics and Proteomics
  • Source
    • "Cytoplasmic viral RNA degradation pathways are important for the suppression of viral replication. The Xrn1 RNA 5 0 À3 0 exonuclease plays a crucial role in HCV RNA degradation and suppresses HCV replication (Li et al., 2013b). The zinc-finger antiviral protein (ZAP) is a host antiviral factor required for the degradation of viral RNA (Chen et al., 2008; Guo et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: RIG-I-mediated type I interferon (IFN) production and nuclease-mediated viral RNA degradation are essential for antiviral innate immune responses. DDX60 is an IFN-inducible cytoplasmic helicase. Here, we report that DDX60 is a sentinel for both RIG-I activation and viral RNA degradation. We show that DDX60 is an upstream factor of RIG-I that activates RIG-I signaling in a ligand-specific manner. DDX60 knockout attenuates RIG-I signaling and significantly reduces virus-induced type I IFN production in vivo. In addition, we show that DDX60 is involved in RIG-I-independent viral RNA degradation. DDX60 and RIG-I adaptor MAVS double-knockout mice reveal a role for DDX60-dependent RNA degradation in antiviral responses. Several viruses induced DDX60 phosphorylation via epidermal growth factor receptor (EGFR), leading to attenuation of the DDX60 antiviral activities. Our results define DDX60 as a sentinel for cytoplasmic antiviral response, which is counteracted by virus-mediated EGF receptor activation. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
    Full-text · Article · May 2015 · Cell Reports
  • Source
    • "Nascent RNA genomes are translated to produce new viral proteins, serve as new/additional RNA templates for further RNA replication and are progressively assembled to form infectious virions. HCV replication is dependent on microRNA 122 (miR-122) [97], a liver-specific microRNA that recruits Argonaute 2 to the 5 0 end of the viral genome [98], stabilizing it and slowing its degradation by the 5 0 exonuclease Xrn1 [99]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) is an important human pathogen that causes hepatitis, liver cirrhosis and hepatocellular carcinoma. It imposes a serious problem to public health in the world as the population of chronically infected HCV patients who are at risk of progressive liver disease is projected to increase significantly in the next decades. However, the arrival of new antiviral molecules is progressively changing the landscape of hepatitis C treatment. The search for new anti-HCV therapies has also been a driving force to better understand how HCV interacts with its host, and major progresses have been made on the various steps of the HCV life cycle. Here, we review the most recent advances in the fast growing knowledge on HCV life cycle and interaction with host factors and pathways.
    Preview · Article · Nov 2014 · Journal of Hepatology
Show more